sotalol has been researched along with Substance-Related Disorders in 2 studies
Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.
Substance-Related Disorders: Disorders related to substance use or abuse.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The issue of drug abuse becomes increasingly prominent when the dosage forms can be readily manipulated to release a high amount of opioid or to extract the drug in certain products or solvents." | 1.43 | Risk based in vitro performance assessment of extended release abuse deterrent formulations. ( Al-Ghabeish, M; Calderon, SN; Gupta, A; Khan, MA; Xu, X, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, X | 1 |
| Gupta, A | 1 |
| Al-Ghabeish, M | 1 |
| Calderon, SN | 1 |
| Khan, MA | 1 |
| Whitlock, FA | 1 |
| Price, J | 1 |
1 review available for sotalol and Substance-Related Disorders
| Article | Year |
|---|---|
Use of beta-adrenergic receptor blocking drugs in psychiatry.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alcoholism; Anxiety; Chlordiazepoxide; Di | 1974 |
1 other study available for sotalol and Substance-Related Disorders
| Article | Year |
|---|---|
Risk based in vitro performance assessment of extended release abuse deterrent formulations.
Topics: Analgesics, Opioid; Delayed-Action Preparations; Drug Administration Routes; Drug Compounding; Human | 2016 |